Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ABCB Ameris Bancorp	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$64.00 -1.8%	$69.00 ➝ $73.00	Buy ➝ Buy
ABEO Abeona Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.02 +3.8%	$18.00 ➝ $18.00	Overweight ➝ Overweight
ACET Adicet Bio	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.53 +0.7%	$5.00 ➝ $5.00	Outperform ➝ Outperform
ACGL Arch Capital Group	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$113.24 +1.6%	$116.00 ➝ $138.00	Buy ➝ Buy
ACHC Acadia Healthcare	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.40 -1.3%	$94.00 ➝ $94.00	Outperform ➝ Outperform
ACN Accenture	Reiterated by	Piper Sandler Companies Subscribe to MarketBeat All Access for the recommendation accuracy rating		$336.22 +0.3%	$329.00	Neutral
My grim warning about AI stocks (Ad) Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming. So go here now to read my new report The Big AI Die-Up… while you still can.
ACN Accenture	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$336.22 +0.3%	$320.00 ➝ $329.00	Neutral ➝ Neutral
ACRE Ares Commercial Real Estate	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Fandetti Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.37 -5.6%	$7.50 ➝ $7.00	Equal Weight ➝ Underweight
ADMA ADMA Biologics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.98 +1.2%	$20.00 ➝ $20.00	Overweight ➝ Overweight
ADNT Adient	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.67 +0.4%	$29.00 ➝ $27.00	Overweight ➝ Overweight
AEE Ameren	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$85.62 +2.4%	$91.00 ➝ $96.00	Overweight ➝ Overweight
AEIS Advanced Energy Industries	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$101.59 -0.2%	$128.00	Outperform
AEP American Electric Power	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$102.15 +0.4%	$107.00	Hold
AFRM Affirm	Initiated by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.93 -0.1%	$52.00	Positive
AGIO Agios Pharmaceuticals	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.55 -1.8%		Overweight
AGNC AGNC Investment	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Fandetti Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.49 -0.7%	$10.00 ➝ $12.00	Equal Weight ➝ Overweight
AHR American Healthcare REIT	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.68 +2.0%	$18.00 ➝ $30.00	Market Outperform ➝ Market Outperform
AHR American Healthcare REIT	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.68 +2.0%	$22.00 ➝ $27.00	Buy ➝ Buy
AJG Arthur J. Gallagher & Co.	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$276.06 -2.2%	$301.00 ➝ $309.00	Overweight ➝ Overweight
AJG Arthur J. Gallagher & Co.	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$276.06 -2.2%	$265.00 ➝ $275.00	Hold ➝ Hold
AJG Arthur J. Gallagher & Co.	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$276.06 -2.2%	$254.00 ➝ $293.00	Neutral ➝ Neutral
AJG Arthur J. Gallagher & Co.	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$276.06 -2.2%	$310.00 ➝ $320.00	Outperform ➝ Outperform
ALGS Aligos Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Arce Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.14 -10.2%	$75.00 ➝ $75.00	Buy ➝ Buy
ALV Autoliv	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$92.85 -3.8%	$103.00 ➝ $102.00	Equal Weight ➝ Equal Weight
AMAT Applied Materials	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$192.16 -2.3%	$245.00 ➝ $225.00	Outperform ➝ Outperform
AMKR Amkor Technology	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$30.96 -2.2%	$38.00	Overweight
AMX América Móvil	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.08 -4.0%	$18.90 ➝ $17.80	Sector Perform ➝ Sector Perform
AMZN Amazon.com	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$191.60 +0.9%	$225.00 ➝ $240.00	Outperform ➝ Outperform
ANGO AngioDynamics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.54 -2.1%	$14.00 ➝ $14.00	Buy ➝ Buy
APLS Apellis Pharmaceuticals	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.51 -11.5%	$85.00 ➝ $85.00	Buy ➝ Buy
APLS Apellis Pharmaceuticals	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.51 -11.5%	$42.00 ➝ $39.00	Neutral ➝ Neutral
APTV Aptiv	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Langan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$69.84 -1.0%	$78.00 ➝ $87.00	Equal Weight ➝ Overweight
ASMB Assembly Biosciences	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.43 +5.0%	$2.00 ➝ $35.00	Hold ➝ Buy
ASML ASML	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$795.28 -4.0%		Overweight ➝ Equal Weight
ATKR Atkore	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$87.02 -2.4%	$160.00 ➝ $130.00	Buy ➝ Buy
AUNA Auna	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.44 -0.3%	$14.00 ➝ $13.00	Overweight ➝ Overweight
AWK American Water Works	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$147.23 -1.2%	$140.00	Underperform
AZO AutoZone	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3,020.66 -0.6%	$3,900.00 ➝ $3,350.00	Outperform ➝ Outperform
BANC Banc of California	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.05 -2.1%	$15.00 ➝ $16.00	Hold ➝ Hold
BCO Brink's	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$112.93 +1.0%	$110.00 ➝ $144.00	Buy ➝ Buy
Must-Know for Trading Options (Ad) Options are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a row! But – knowing what the options trading landscape looks like, and what you're up against is a must. So make sure you claim your free seat by clicking here now.
BLDR Builders FirstSource	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$197.74 -2.0%	$190.00 ➝ $230.00	Buy ➝ Buy
BNS Bank of Nova Scotia	Upgraded by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$73.35 +1.9%	C$78.00 ➝ C$82.00	Neutral ➝ Outperform
BOKF BOK Financial	Upgraded by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. King Subscribe to MarketBeat All Access for the recommendation accuracy rating	$105.83 -1.6%	$112.00 ➝ $123.00	Hold ➝ Buy
BURBY Burberry Group	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.06 -3.1%		Hold ➝ Underperform
BXMT Blackstone Mortgage Trust	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.83 -2.0%	$19.00 ➝ $22.00	Overweight ➝ Overweight
CADE Cadence Bank	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.99 -2.0%	$38.00 ➝ $37.00	Buy ➝ Buy
CAPR Capricor Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.05 +1.2%	$8.00 ➝ $8.00	Overweight ➝ Overweight
CATY Cathay General Bancorp	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$43.38 -1.8%	$45.00 ➝ $47.00	Hold ➝ Hold
CBRL Cracker Barrel Old Country Store	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.57 +1.1%	$40.00 ➝ $42.00	Underperform ➝ Underperform
CBRL Cracker Barrel Old Country Store	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.57 +1.1%	$50.00 ➝ $45.00	Hold ➝ Hold
CBRL Cracker Barrel Old Country Store	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.57 +1.1%	$42.00 ➝ $44.00	Hold ➝ Hold
CCA Cogeco Communications	Upgraded by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$68.12 +1.0%	C$64.00 ➝ C$80.00	Sector Perform ➝ Outperform
CCL Carnival Co. &	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.00 +1.3%	$25.00 ➝ $27.00	Buy ➝ Buy
CDE Coeur Mining	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.97 +0.9%	$6.25 ➝ $7.00	Market Perform ➝ Market Perform
CDXS Codexis	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Kluska Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.10 -3.4%	$11.00 ➝ $11.00	Overweight ➝ Overweight
CFLT Confluent	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Ved Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.36 -1.5%	$33.00 ➝ $28.00	Outperform ➝ Outperform
CFLT Confluent	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.36 -1.5%	$31.00 ➝ $27.00	Buy ➝ Buy
CFR Cullen/Frost Bankers	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$114.24 -1.1%	$126.00 ➝ $123.00	Hold ➝ Hold
CHRD Chord Energy	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$136.73 +0.3%	$200.00 ➝ $200.00	Outperform ➝ Outperform
CHWY Chewy	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.75 -4.3%	$35.00 ➝ $35.00	Overweight ➝ Overweight
CMA Comerica	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$61.49 +0.6%	$53.00 ➝ $66.00	Hold ➝ Hold
CMTG Claros Mortgage Trust	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Fandetti Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.04 -6.3%	$8.00	Equal Weight ➝ Underweight
CNC Centene	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$75.61 0.0%	$90.00 ➝ $90.00	Overweight ➝ Overweight
CNXC Concentrix	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.38 -1.2%	$84.00 ➝ $84.00	Outperform ➝ Outperform
COF Capital One Financial	Initiated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$152.28 -0.5%	$190.00	Buy
COLB Columbia Banking System	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.80 -1.8%	$29.00 ➝ $28.00	Hold ➝ Hold
CPB Campbell Soup	Upgraded by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.21 +0.7%	$59.00	Hold ➝ Buy
CRBP Corbus Pharmaceuticals	Target Lowered by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.51 -62.3%	$85.00 ➝ $40.00	Buy ➝ Buy
CRBP Corbus Pharmaceuticals	Target Lowered by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.51 -62.3%	$85.00 ➝ $51.00	Outperform ➝ Outperform
CRBP Corbus Pharmaceuticals	Reiterated by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.51 -62.3%	$74.00 ➝ $74.00	Outperform ➝ Outperform
CRBP Corbus Pharmaceuticals	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.51 -62.3%	$82.00 ➝ $82.00	Outperform ➝ Outperform
CRL Charles River Laboratories International	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$205.79 -1.8%	$191.00 ➝ $190.00	Neutral ➝ Neutral
CRM Salesforce	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$266.80 +0.3%	$345.00 ➝ $345.00	Buy ➝ Buy
CSCO Cisco Systems	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.97 +1.0%	$55.00 ➝ $60.00	Outperform ➝ Outperform
CWEN Clearway Energy	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.60 +1.8%	$35.00	Buy
CWH Camping World	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.35 -0.7%	$26.00 ➝ $28.00	Buy ➝ Buy
CYBR CyberArk Software	Initiated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$280.62 +3.5%	$328.00	Outperform
CYTK Cytokinetics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$53.77 -3.3%	$90.00 ➝ $90.00	Buy ➝ Buy
D Dominion Energy	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$57.93 +0.8%	$58.00	Hold
DAN Dana	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Langan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.87 -5.7%	$13.00 ➝ $9.00	Equal Weight ➝ Underweight
DAVA Endava	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.62 -3.8%	$66.00 ➝ $55.00	Positive ➝ Positive
DAVA Endava	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.62 -3.8%	$42.00 ➝ $33.00	Buy ➝ Buy
DCGO DocGo	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.48 -3.3%	$5.00 ➝ $5.00	Overweight ➝ Overweight
DECK Deckers Outdoor	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$150.73 -0.9%	$1,090.00 ➝ $180.00	Overweight ➝ Overweight
DFY Definity Financial	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$52.25 +4.8%	C$52.00 ➝ C$55.00
DFY Definity Financial	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$52.25 +4.8%	C$51.00 ➝ C$53.00
DGHI Digihost Technology	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.15 -3.4%	$2.50 ➝ $2.50	Buy ➝ Buy
DINO HF Sinclair	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.25 -2.1%	$58.00 ➝ $49.00	Overweight ➝ Overweight
DK Delek US	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.70 -3.1%	$25.00 ➝ $19.00	Neutral ➝ Neutral
DLB Dolby Laboratories	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Goss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$73.26 +0.9%	$100.00 ➝ $100.00	Outperform ➝ Outperform
Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad) Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now. Click here to see it because it’s a SHOCKER…
DNA Ginkgo Bioworks	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.01 -3.6%	$3.00 ➝ $10.00	Buy ➝ Buy
DPZ Domino's Pizza	Reiterated by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$414.42 +0.7%	$419.00 ➝ $419.00	Hold ➝ Hold
DRI Darden Restaurants	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.17 -1.2%	$184.00 ➝ $195.00	Buy ➝ Buy
DRI Darden Restaurants	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Saleh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$170.17 -1.2%	$175.00 ➝ $195.00	Buy ➝ Buy
DRI Darden Restaurants	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.17 -1.2%	$165.00 ➝ $175.00	Market Perform ➝ Market Perform
DRI Darden Restaurants	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.17 -1.2%	$165.00 ➝ $176.00	Overweight ➝ Overweight
DRI Darden Restaurants	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.17 -1.2%	$159.00 ➝ $177.00	Neutral ➝ Neutral
DRI Darden Restaurants	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.17 -1.2%	$180.00 ➝ $192.00	Overweight ➝ Overweight
DRI Darden Restaurants	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.17 -1.2%	$188.00 ➝ $195.00	Buy ➝ Buy
DRI Darden Restaurants	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.17 -1.2%	$170.00 ➝ $194.00	Overweight ➝ Overweight
DRI Darden Restaurants	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.17 -1.2%	$185.00 ➝ $195.00	Buy ➝ Buy
DRI Darden Restaurants	Upgraded by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Palmer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$170.17 -1.2%	$165.00 ➝ $205.00	In-Line ➝ Outperform
DRI Darden Restaurants	Downgraded by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Gargiulo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$170.17 -1.2%	$190.00 ➝ $180.00	Outperform ➝ Market Perform
DRI Darden Restaurants	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.17 -1.2%	$170.00 ➝ $200.00	Outperform ➝ Outperform
DRI Darden Restaurants	Target Raised by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Salera Subscribe to MarketBeat All Access for the recommendation accuracy rating	$170.17 -1.2%	$159.00 ➝ $164.00	Equal Weight ➝ Equal Weight
DRI Darden Restaurants	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.17 -1.2%	$175.00 ➝ $188.00	Overweight ➝ Overweight
DRI Darden Restaurants	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.17 -1.2%	$160.00 ➝ $165.00	Equal Weight ➝ Equal Weight
ED Consolidated Edison	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	W. Appicelli Subscribe to MarketBeat All Access for the recommendation accuracy rating	$103.35 +1.2%	$105.00 ➝ $106.00	Neutral ➝ Neutral
EFN Element Fleet Management	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$28.37 -0.1%	C$30.00 ➝ C$32.00
ELV Elevance Health	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$539.86 +0.3%	$600.00 ➝ $600.00	Overweight ➝ Overweight
EMA Emera	Target Set by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$52.48 +1.1%	C$55.00	Neutral
ESTC Elastic	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.39 +0.1%	$106.00 ➝ $90.00	Equal Weight ➝ Equal Weight
ETNB 89bio	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.19 -1.2%	$29.00 ➝ $29.00	Overweight ➝ Overweight
ETR Entergy	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$129.25 +1.2%	$143.00 ➝ $144.00	Buy ➝ Buy
EVAX Evaxion Biotech A/S	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.99 -5.1%	$14.00 ➝ $14.00	Buy ➝ Buy
EWBC East West Bancorp	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$82.57 -0.8%	$96.00 ➝ $93.00	Buy ➝ Buy
EWCZ European Wax Center	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.04 -4.6%	$8.00 ➝ $8.00	Outperform ➝ Outperform
EXC Exelon	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$40.27 +2.5%	$40.00 ➝ $43.00	Neutral ➝ Neutral
EXEL Exelixis	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.42 -1.5%	$29.00 ➝ $29.00	Market Outperform ➝ Market Outperform
FDS FactSet Research Systems	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$465.91 -0.8%	$455.00 ➝ $485.00	Neutral ➝ Neutral
FDS FactSet Research Systems	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$465.91 -0.8%	$464.00 ➝ $503.00	Sector Perform ➝ Sector Perform
FDS FactSet Research Systems	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Haas Subscribe to MarketBeat All Access for the recommendation accuracy rating	$465.91 -0.8%	$435.00 ➝ $503.00	Equal Weight ➝ Equal Weight
FDS FactSet Research Systems	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$465.91 -0.8%	$451.00 ➝ $469.00	Hold ➝ Hold
FDS FactSet Research Systems	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$465.91 -0.8%	$440.00 ➝ $471.00	Market Perform ➝ Market Perform
FDX FedEx	Downgraded by	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Jain Subscribe to MarketBeat All Access for the recommendation accuracy rating	$254.64 -15.2%		Strong-Buy ➝ Hold
FDX FedEx	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$359.00 ➝ $350.00	Overweight ➝ Overweight
FDX FedEx	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$345.00 ➝ $330.00	Positive ➝ Positive
FDX FedEx	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$327.00 ➝ $321.00	Buy ➝ Buy
FDX FedEx	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$350.00 ➝ $350.00	Overweight ➝ Overweight
FDX FedEx	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$333.00 ➝ $311.00	Buy ➝ Buy
FDX FedEx	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$325.00 ➝ $300.00	Market Perform ➝ Market Perform
FDX FedEx	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$215.00 ➝ $200.00	Equal Weight ➝ Underweight
FDX FedEx	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$340.00 ➝ $320.00	Outperform ➝ Outperform
FDX FedEx	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$334.00 ➝ $328.00	Buy ➝ Buy
FDX FedEx	Downgraded by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$300.00	Buy ➝ Hold
FDX FedEx	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$335.00 ➝ $318.00	Outperform ➝ Outperform
FDX FedEx	Target Lowered by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$335.00 ➝ $330.00	Buy ➝ Buy
FDX FedEx	Target Raised by	Bernstein Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$305.00 ➝ $337.00	Overweight ➝ Overweight
FDX FedEx	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$254.64 -15.2%	$333.00 ➝ $332.00
FE FirstEnergy	Upgraded by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.00 +1.8%	$50.00	Hold ➝ Buy
The Perfect Storm for an EV Revolt (Ad) Not many people realize there’s a "perfect storm" for profits unfolding in the auto industry - today. Global auto manufacturing and sales are projected to top $6.4 trillion in revenue this year. Click here for details...
FFIN First Financial Bankshares	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.10 -1.9%	$39.00 ➝ $40.00	Hold ➝ Hold
FOLD Amicus Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.29 +2.6%	$20.00 ➝ $20.00	Overweight ➝ Overweight
FOUR Shift4 Payments	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.90 +1.2%	$75.00 ➝ $95.00	Overweight ➝ Overweight
FTS Fortis	Target Set by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$60.60 +0.2%	C$60.00	Underperform
FTS Fortis	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.68 +0.2%		Underperform
GBCI Glacier Bancorp	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.24 -2.6%	$46.00 ➝ $50.00	Hold ➝ Hold
GE General Electric	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$187.43 +0.7%	$210.00 ➝ $212.00	Buy ➝ Buy
GEV GE Vernova	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$245.46 +0.4%	$261.00 ➝ $293.00	Buy ➝ Buy
GIS General Mills	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$74.51 -0.5%	$67.00 ➝ $74.00	Equal Weight ➝ Equal Weight
GIS General Mills	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$74.51 -0.5%	$72.00 ➝ $75.00	Hold ➝ Hold
GLW Corning	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.50 +0.2%	$46.00 ➝ $51.00	Buy ➝ Buy
GLW Corning	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.50 +0.2%	$47.00 ➝ $51.00	Outperform ➝ Outperform
GLW Corning	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.50 +0.2%	$46.00 ➝ $55.00	Positive ➝ Positive
GMAB Genmab A/S	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.53 -3.6%	$50.00 ➝ $50.00	Buy ➝ Buy
GNFT Genfit	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.84 +15.5%	$13.00 ➝ $13.00	Buy ➝ Buy
GRYP Gryphon Digital Mining	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Dede Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.50 -3.8%		Neutral
HCAT Health Catalyst	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.69 -1.6%	$16.00 ➝ $16.00	Overweight ➝ Overweight
HLN Haleon	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.52 +0.6%	$9.90 ➝ $10.95	Overweight ➝ Overweight
HQY HealthEquity	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$79.53 +1.2%	$105.00 ➝ $105.00	Outperform ➝ Outperform
HSIC Henry Schein	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$71.15 -1.9%	$82.00 ➝ $82.00	Outperform ➝ Outperform
HSII Heidrick & Struggles International	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.10 -1.9%	$44.00 ➝ $44.00	Outperform ➝ Outperform
HUM Humana	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$310.41 -0.5%	$395.00 ➝ $395.00	Neutral ➝ Neutral
HUMA Humacyte	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.20 -4.6%	$13.00 ➝ $13.00	Overweight ➝ Overweight
HUT Hut 8	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Colonnese Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.17 -2.3%	$13.50 ➝ $13.50	Buy ➝ Buy
HWC Hancock Whitney	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.43 -1.6%	$57.00 ➝ $56.00	Hold ➝ Hold
IBTX Independent Bank Group	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$58.83 -3.6%	$65.00 ➝ $66.00	Hold ➝ Hold
ICFI ICF International	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$167.51 -0.4%	$174.00 ➝ $174.00	Outperform ➝ Outperform
ICLR ICON Public	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$303.07 +0.7%	$368.00 ➝ $340.00	Outperform ➝ Outperform
IDA IDACORP	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$102.22 -0.2%	$110.00	Hold
IQV IQVIA	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$242.12 -1.0%	$251.00 ➝ $256.00	Neutral ➝ Neutral
IRON Disc Medicine	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.11 -1.0%	$85.00 ➝ $85.00	Overweight ➝ Overweight
JNJ Johnson & Johnson	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$164.16 -0.4%	$175.00 ➝ $175.00	Outperform ➝ Outperform
KAI Kadant	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$332.98 -2.5%	$360.00 ➝ $360.00	Outperform ➝ Outperform
KAR OPENLANE	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.63 -1.7%	$25.00 ➝ $25.00	Outperform ➝ Outperform
KOP Koppers	Upgraded by	Singular Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Marsh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.51 -2.4%		Strong-Buy
KREF KKR Real Estate Finance Trust	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.61 -1.9%	$13.00 ➝ $14.00	Overweight ➝ Overweight
LCII LCI Industries	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$120.86 -2.3%	$100.00 ➝ $108.00	Hold ➝ Hold
LEA Lear	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.02 -1.8%	$131.00 ➝ $114.00	Equal Weight ➝ Equal Weight
LEN Lennar	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Mccanless Subscribe to MarketBeat All Access for the recommendation accuracy rating	$182.19 -5.3%	$144.00 ➝ $144.00	Neutral ➝ Neutral
LEN Lennar	Target Raised by	Bank Of America (Bofa) Subscribe to MarketBeat All Access for the recommendation accuracy rating		$182.19 -5.3%	$171.00 ➝ $190.00	Neutral ➝ Neutral
LFMD LifeMD	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.91 -7.0%	$15.00 ➝ $15.00	Overweight ➝ Overweight
LH Laboratory Co. of America	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$222.22 -1.1%	$278.00 ➝ $282.00	Outperform ➝ Outperform
LINC Lincoln Educational Services	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.47 -0.9%	$16.00 ➝ $16.00	Outperform ➝ Outperform
LMAT LeMaitre Vascular	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$89.96 -0.2%	$92.00 ➝ $92.00	Outperform ➝ Outperform
LNT Alliant Energy	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.72 -0.1%	$64.00 ➝ $65.00	Neutral ➝ Neutral
LOB Live Oak Bancshares	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.89 -1.7%	$51.00 ➝ $57.00	Buy ➝ Buy
LOPE Grand Canyon Education	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$142.78 +1.0%	$165.00 ➝ $165.00	Outperform ➝ Outperform
LPTH LightPath Technologies	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.26 -0.8%	$3.00 ➝ $3.00	Buy ➝ Buy
LRCX Lam Research	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$773.19 -2.0%	$1,050.00 ➝ $950.00	Outperform ➝ Outperform
LRN Stride	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$85.03 +0.9%	$90.00 ➝ $90.00	Outperform ➝ Outperform
Must-Know for Trading Options (Ad) Options are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a row! But – knowing what the options trading landscape looks like, and what you're up against is a must. So make sure you claim your free seat by clicking here now.
LTC LTC Properties	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.00 -0.9%	$40.00 ➝ $40.00	Outperform ➝ Outperform
MASI Masimo	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$121.42 +8.7%		Hold
MCS Marcus	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.85 +0.3%	$20.00 ➝ $20.00	Outperform ➝ Outperform
MDA MDA Space	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$16.82 +2.3%	C$18.00 ➝ C$20.00
MEDP Medpace	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$365.70 -0.9%	$430.00 ➝ $413.00	Outperform ➝ Outperform
MELI MercadoLibre	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2,103.75 -0.3%	$2,175.00 ➝ $2,500.00	Overweight ➝ Overweight
MGA Magna International	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.00 -1.2%	$43.00 ➝ $44.00	Equal Weight ➝ Equal Weight
MMSI Merit Medical Systems	Target Raised by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$99.56 -0.7%	$100.00 ➝ $114.00	Outperform ➝ Outperform
MPC Marathon Petroleum	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$164.39 -1.2%	$168.00 ➝ $145.00	Neutral ➝ Neutral
MTDR Matador Resources	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$52.20	$75.00 ➝ $75.00	Outperform ➝ Outperform
NA National Bank of Canada	Downgraded by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$127.22 -0.6%		Outperform ➝ Neutral
NFLX Netflix	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$701.03 -0.5%	$635.00 ➝ $635.00	Neutral ➝ Neutral
NJR New Jersey Resources	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$47.64 -0.1%	$45.00 ➝ $47.00	Neutral ➝ Neutral
NKE NIKE	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.52 +6.8%	$86.00 ➝ $95.00	Overweight ➝ Overweight
NKE NIKE	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.52 +6.8%	$100.00 ➝ $100.00	Outperform ➝ Outperform
NKE NIKE	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.52 +6.8%	$81.00 ➝ $85.00	Hold ➝ Hold
NKE NIKE	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.52 +6.8%	$80.00 ➝ $80.00	Neutral ➝ Neutral
NKE NIKE	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.52 +6.8%	$79.00 ➝ $79.00	Equal Weight ➝ Equal Weight
NKE NIKE	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.52 +6.8%	$92.00 ➝ $92.00	Buy ➝ Buy
NKE NIKE	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.52 +6.8%	$100.00 ➝ $110.00	Outperform ➝ Outperform
NKE NIKE	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.52 +6.8%	$105.00 ➝ $110.00	Outperform ➝ Outperform
NLY Annaly Capital Management	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Fandetti Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.88 +0.4%	$19.00 ➝ $23.00	Equal Weight ➝ Overweight
NSIT Insight Enterprises	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$213.84 +0.4%	$225.00 ➝ $225.00	Outperform ➝ Outperform
NTR Nutrien	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$47.06 -1.8%	$60.00 ➝ $60.00	Outperform ➝ Outperform
OCFC OceanFirst Financial	Target Raised by	Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.21 -3.7%	$19.50 ➝ $21.50	Outperform
OLLI Ollie's Bargain Outlet	Reiterated by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$98.99 +1.2%	$110.00 ➝ $110.00	Buy ➝ Buy
ONC Oncolytics Biotech	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$1.26 -2.3%	C$3.00 ➝ C$3.50
OPK OPKO Health	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.48 -6.9%	$2.25 ➝ $2.25	Outperform ➝ Outperform
OZK Bank OZK	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.76 -2.8%	$49.00 ➝ $48.00	Hold ➝ Hold
PAL Proficient Auto Logistics	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Paris Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.44 -4.9%	$22.00 ➝ $22.00	Outperform ➝ Outperform
PARR Par Pacific	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Todd Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.35 -1.7%	$37.00 ➝ $23.00	Overweight ➝ Neutral
PATK Patrick Industries	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$146.96 +0.4%	$150.00 ➝ $165.00	Buy ➝ Buy
PB Prosperity Bancshares	Downgraded by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. King Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.60 -2.2%	$81.00 ➝ $79.00	Buy ➝ Hold
PBF PBF Energy	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Todd Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.02 -5.5%	$47.00 ➝ $25.00	Neutral ➝ Underweight
PEP PepsiCo	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$171.18 -2.0%	$185.00 ➝ $185.00	Overweight ➝ Equal Weight
PGNY Progyny	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.62 +1.0%	$24.00 ➝ $18.00	Hold ➝ Hold
PL Planet Labs PBC	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.06 -2.8%	$4.00 ➝ $4.00	Market Outperform ➝ Market Outperform
PNFP Pinnacle Financial Partners	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$99.99 -0.6%	$101.00 ➝ $113.00	Buy ➝ Buy
POR Portland General Electric	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$47.70 -0.4%	$48.00	Hold
PPBT Purple Biotech	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.89 -1.3%	$8.00 ➝ $33.00	Buy ➝ Buy
PRDO Perdoceo Education	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.23 -0.5%	$30.00 ➝ $30.00	Outperform ➝ Outperform
PSX Phillips 66	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$129.97 -1.9%	$151.00 ➝ $136.00	Overweight ➝ Overweight
QUAD Quad/Graphics	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.46 +2.1%	$8.50 ➝ $8.50	Outperform ➝ Outperform
QURE uniQure	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.36 -5.5%	$28.00 ➝ $28.00	Overweight ➝ Overweight
RDDT Reddit	Initiated by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$66.17 +2.5%	$75.00	Buy
RF Regions Financial	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.11 -1.1%	$23.00 ➝ $25.00	Hold ➝ Hold
RIGL Rigel Pharmaceuticals	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.76 +0.5%	$15.00 ➝ $15.00	Neutral ➝ Neutral
RL Ralph Lauren	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$185.31 +0.3%	$195.00 ➝ $207.00	Outperform ➝ Outperform
RNST Renasant	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.40 -3.5%	$38.00 ➝ $37.00	Hold ➝ Hold
RPD Rapid7	Downgraded by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Hedberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$35.20 +2.5%	$50.00 ➝ $40.00	Outperform ➝ Sector Perform
RWT Redwood Trust	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.93 -1.6%	$7.50 ➝ $8.50	Equal Weight ➝ Equal Weight
RZLT Rezolute	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.08 +5.4%	$7.00 ➝ $7.00	Market Outperform ➝ Market Outperform
SBGI Sinclair	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.67 +4.3%	$16.40 ➝ $16.50	Neutral ➝ Neutral
SEAT Vivid Seats	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.69 -4.4%	$10.00 ➝ $9.00	Buy ➝ Buy
SJW SJW Group	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$58.38 -2.7%	$65.00	Neutral
SKYE Skye Bioscience	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Kluska Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.14 -42.8%	$14.00 ➝ $14.00	Overweight ➝ Overweight
SKYE Skye Bioscience	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Kluska Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.14 -42.8%	$14.00 ➝ $14.00	Overweight ➝ Overweight
SKYE Skye Bioscience	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.14 -42.8%	$20.00 ➝ $20.00	Overweight ➝ Overweight
SKYE Skye Bioscience	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.14 -42.8%	$20.00 ➝ $20.00	Overweight ➝ Overweight
SLNO Soleno Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.61 -2.1%	$67.00 ➝ $67.00	Overweight ➝ Overweight
SNA Snap-on	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$283.19 -1.0%	$325.00 ➝ $325.00	Outperform ➝ Outperform
SNAP Snap	Initiated by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.05 -0.2%	$11.00	Neutral
SNV Synovus Financial	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$45.00 -1.3%	$50.00 ➝ $52.00	Buy ➝ Buy
SO Southern	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$89.70 +0.9%	$94.00	Hold
SO Southern	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$89.70 +0.9%	$90.00 ➝ $91.00	Neutral ➝ Neutral
SPRY ARS Pharmaceuticals	Target Raised by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.77 -0.6%	$21.00 ➝ $25.00	Outperform ➝ Outperform
SRPT Sarepta Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$127.21 +0.1%	$152.00 ➝ $152.00	Neutral ➝ Neutral
SSB SouthState	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$98.78 -2.8%	$109.00 ➝ $111.00	Hold ➝ Hold
SSNC SS&C Technologies	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$75.53 -1.2%	$88.00 ➝ $92.00	Buy ➝ Buy
STWD Starwood Property Trust	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.96 -0.7%	$22.00 ➝ $24.00	Outperform ➝ Outperform
TCBI Texas Capital Bancshares	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.00 -2.6%	$70.00 ➝ $80.00	Hold ➝ Hold
TEL TE Connectivity	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$148.11 -0.9%	$155.00 ➝ $153.00	Equal Weight ➝ Equal Weight
TEX Terex	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.86 -3.7%	$74.00 ➝ $63.00	Buy ➝ Buy
TEX Terex	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.86 -3.7%	$72.00 ➝ $62.00	Neutral ➝ Neutral
THO THOR Industries	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$103.51 -3.6%	$95.00 ➝ $105.00	Hold ➝ Hold
TIGO Millicom International Cellular	Upgraded by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Coello Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.84 +1.6%	$30.00 ➝ $37.30	Sector Perform ➝ Sector Outperform
TILE Interface	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Paris Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.97 -0.2%	$22.00 ➝ $22.00	Outperform ➝ Outperform
TMO Thermo Fisher Scientific	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$613.69 -1.1%	$767.00 ➝ $767.00	Outperform ➝ Outperform
TMO Thermo Fisher Scientific	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$613.69 -1.1%	$655.00 ➝ $680.00	Overweight ➝ Overweight
TMO Thermo Fisher Scientific	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$613.69 -1.1%	$650.00 ➝ $670.00	Overweight ➝ Overweight
TMO Thermo Fisher Scientific	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$613.69 -1.1%	$615.00 ➝ $680.00	Buy ➝ Buy
TMUS T-Mobile US	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$199.44 -0.1%	$220.00 ➝ $250.00	Buy ➝ Buy
TRMK Trustmark	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.72 -2.6%	$37.00 ➝ $35.00	Hold ➝ Hold
TRUP Trupanion	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.80 +1.9%	$47.00 ➝ $56.00	Buy ➝ Buy
UCB United Community Banks	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.54 -2.6%	$31.00 ➝ $32.00	Hold ➝ Hold
UNP Union Pacific	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$245.39 -1.2%	$275.00 ➝ $275.00	Outperform ➝ Outperform
UNP Union Pacific	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$245.39 -1.2%	$280.00 ➝ $275.00	Outperform ➝ Outperform
UPST Upstart	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Dolev Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.74 -0.7%	$33.00 ➝ $48.00	Outperform ➝ Outperform
USPH U.S. Physical Therapy	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$83.28 -2.0%	$108.00 ➝ $108.00	Outperform ➝ Outperform
VC Visteon	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Langan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$95.30 +0.2%	$115.00 ➝ $122.00	Equal Weight ➝ Overweight
VIV Telefônica Brasil	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.00 -1.2%	$9.20 ➝ $10.40	Sector Perform ➝ Sector Perform
VLO Valero Energy	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Todd Subscribe to MarketBeat All Access for the recommendation accuracy rating	$134.46 -3.0%	$169.00 ➝ $123.00	Overweight ➝ Neutral
VSAT Viasat	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.77 -1.6%	$31.00 ➝ $19.00	Buy ➝ Buy
VST Vistra	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$107.88 +16.6%	$120.00 ➝ $125.00	Outperform ➝ Outperform
WAL Western Alliance Bancorporation	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$87.69 -0.8%	$88.00 ➝ $100.00	Buy ➝ Buy
WGO Winnebago Industries	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.11 -0.7%	$65.00 ➝ $68.00	Buy ➝ Buy
WTFC Wintrust Financial	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.26 -1.8%	$118.00 ➝ $123.00	Buy ➝ Buy
WTRG Essential Utilities	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.00 -0.8%	$45.00	Buy
XEL Xcel Energy	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$64.13 +0.1%	$66.00 ➝ $67.00	Neutral ➝ Neutral
XOMA XOMA	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.19 -5.6%	$117.00 ➝ $117.00	Buy ➝ Buy
XRAY DENTSPLY SIRONA	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.29 -2.3%	$36.00 ➝ $36.00	Outperform ➝ Outperform
ZION Zions Bancorporation, National Association	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$47.99 -0.9%	$54.00 ➝ $52.00	Hold ➝ Hold
ZVRA Zevra Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.06 +0.5%	$18.00 ➝ $20.00	Buy ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:44 AM ET.

(Ad)

Not many people realize there’s a "perfect storm" for profits unfolding in the auto industry - today. Global auto manufacturing and sales are projected to top $6.4 trillion in revenue this year.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

analyst ratings Headlines

Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
By Leo Miller | September 20, 2024
View Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
e.l.f. Beauty: The High-Growth Stock You Shouldn't Ignore
By Leo Miller | September 18, 2024
View e.l.f. Beauty: The High-Growth Stock You Shouldn't Ignore
The Analyst Edge: How to Use Expert Opinions
By Jeffrey Neal Johnson | September 16, 2024
View The Analyst Edge: How to Use Expert Opinions
Analysts See 51% Upside in Coinbase, Is It Time to Buy the Hype?
By Leo Miller | September 16, 2024
View Analysts See 51% Upside in Coinbase, Is It Time to Buy the Hype?
Analysts Recommend These 3 Sector ETFs for Long-Term Growth
By Leo Miller | September 12, 2024
View Analysts Recommend These 3 Sector ETFs for Long-Term Growth
Oracle Can Turn the Magnificent 7 Into 8: Here's Why
By Thomas Hughes | September 10, 2024
View Oracle Can Turn the Magnificent 7 Into 8: Here's Why
Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
By Leo Miller | September 7, 2024
View Blade Air Mobility: This Under-the-Radar Stock Could Double Soon

Top Headlines and Offers

View All

Congress Members Are Buying These 3 Hot Stocks
By Thomas Hughes | September 16, 2024
View Congress Members Are Buying These 3 Hot Stocks
Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion?
By Ryan Hasson | September 17, 2024
View Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion?
Trump’s “Tax Free” Retirement Strategy
From Gold Safe Exchange(Ad)
View Trump’s “Tax Free” Retirement Strategy
Maximize Gains: Invest in AST SpaceMobile’s 5G Breakthrough
By Jea Yu | September 18, 2024
View Maximize Gains: Invest in AST SpaceMobile’s 5G Breakthrough
What the Bulls and Bears Are Saying About NVIDIA Stock
By Chris Markoch | September 18, 2024
View What the Bulls and Bears Are Saying About NVIDIA Stock
3 Undervalued Stocks That Are Too Cheap to Ignore Right Now
By Gabriel Osorio-Mazilli | September 16, 2024
View 3 Undervalued Stocks That Are Too Cheap to Ignore Right Now
625,000% Gain
From Crypto Swap Profits(Ad)
View 625,000% Gain
How the Fed’s Rate Cut Could Supercharge These 3 ETFs
By Nathan Reiff | September 19, 2024
View How the Fed’s Rate Cut Could Supercharge These 3 ETFs
Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
By Ryan Hasson | September 17, 2024
View Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
Wall Street soars to records as Dow leaps 500 in a rate-cut rally that swept the world
By The Associated Press | September 18, 2024
View Wall Street soars to records as Dow leaps 500 in a rate-cut rally that swept the world
High Dividend Yields Make These 2 Shipping Stocks Stand Out
By Nathan Reiff | September 15, 2024
View High Dividend Yields Make These 2 Shipping Stocks Stand Out
Stock market today: Wall Street closes its record-setting week mixed as FedEx slumps and Nike jumps
By The Associated Press | September 20, 2024
View Stock market today: Wall Street closes its record-setting week mixed as FedEx slumps and Nike jumps

Stock Forecasts and Research Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Price Forecasts for Popular Stocks:

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

Stock Price Targets and Analyst Ratings